Reading the tape
NYSE: MTD
Mettler-Toledo International Inc.
Healthcare · Medical - Diagnostics & Research
Market Cap
$26.47B
52w High
$1,525.17
52w Low
$1,052.05
P/E
30.54
Volume
113.16K
Outstanding Shares
20.33M
Price vs Fundamentals
Why The Stock Is Moving
Mixed / unclearLow confidence
Note: The most recent financial data is over 3 months old. Metrics shown may not reflect the latest reporting period.
1Y Price: 19.36%Revenue (TTM): 3.98%FCF (TTM): -1.83%P/FCF: 18th pct
What changed
The stock rose 19.36% over the last year. Revenue grew 3.98% over the trailing twelve months. Operating margin moved from 29.11% to 27.78%. Free cash flow declined 1.83% over the trailing twelve months.
What the market seems to be pricing
The stock has moved higher against modestly weakening underlying metrics. The operating data does not yet tell a clear story — the move may reflect sentiment, sector rotation, or macro factors rather than company-specific earnings power.
What would invalidate this read
Operating margin currently stands at 27.78%. A decisive move in revenue — currently up 3.98% — would be the clearest signal to resolve the ambiguity.
Company profile
Mettler-Toledo International Inc. engages in the manufacture and supply of precision instruments and services worldwide.
CEOPatrick K. Kaltenbach
SectorHealthcare
IndustryMedical - Diagnostics & Research
Employees16,000
IPO dateNov 14, 1997
Valuation
Forward P/E—
EV/EBITDA25.12
Enterprise value$31.01B
Stock splits
No stock splits recorded for this ticker.
Profitability & growth
Revenue growth8.1%
Gross margin57.52%▼1.12%vs FY2024
Operating margin27.78%▼4.56%vs FY2024
ROE-3,677.41%▼440.62%vs FY2024
Analyst consensus
RatingHold
Target price$1,490.83▲14.47%
8
Buy
11
Hold
0
Sell
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.
Next report
May 7, 2026
Q2 FY26 · EPS est $8.70 · Revenue est $943.38M
View